also diagnosed with rheumatoid arthritis and was treated with intra-articular injections of steroids. Approximately three years later, in 1982, she was started on oral diclofenac 25 mg tid. She has taken this drug continually since then with good control of her arthritis.
Her diarrhea consisted of two to six loose, watery bowel motions per day, which would occur at any time and were not related to meals. There was no nocturnal diarrhea. She did not experience any urgency or tenesmus, although she had occasional lower abdominal cramping pain before bowel movements. On examination, the patient was in good general health and no abnormality of the abdomen was detected.
In 1981, she had a sigmoidoscopy, which was negative, and a rectal biopsy, which was normal. Small bowel follow-through revealed some edema and segmental narrowing, thought to be due to spasm of the terminal ileum.
Barium enema was reported as showing small nodular defects consistent with nodular lymphoid hyperplasia and possible isolated small superficial ulcers in the ascending colon. However, these films were not available for review. Because her terminal ileum was subsequently found to be normal, the authors doubt that this initial suggestion was correct.
She was treated conservatively with psyllium hydrophillic mucilloid and loperamide. Because the diarrhea persisted, she had a follow-up air contrast barium enema in 1983, which revealed a normal colon and terminal ileum. She continued in a stable condition until the fall of 1987, when she started to complain of intermittent, dull aching in the midabdominal zone. At times, a cramping pain was present. She was found to have hypochromic, microcytic anemia, with hemoglobin of 79 g/L. Stool specimens were positive for occult blood. In December 1987 a colonoscopy was done; its results noted that she had swollen, indurated folds in the cecum. Biopsies revealed chronic inflammation with focal ulceration. She was started on Asacol (enteric-coated 5-aminosalicylic acid; Procter & Gamble) 800 mg qid, with some improvement of her pain and diarrhea.
During the next year (1988), she continued to be mildly symptomatic with diarrhea, anemia and stool repeatedly positive for occult blood. An upper gastrointestinal barium study and small bowel follow-up were normal. Barium enema revealed scattered diverticula, but no other abnormality. A colonoscopic examination revealed a circular diaphragmatic lesion in the hepatic flexure with a small eccentric round opening.
Because the patient continued to be symptomatic, she underwent a right hemicolectomy. Laparotomy revealed scarring in the region of the hepatic flexure, with increased vascularity of the serosa. Externally, there was slight narrowing of the colon in the hepatic The colectomy specimen revealed four diaphragm-like strictures, located at 13, 17, 20 and 27 cm distal to the ileocecal valve ( Figure 1 ). These were approximately 0.5 cm in length with a 1.0 cm diameter central lumen, which was eccentrically placed towards the mesenteric aspect of the bowel. For the most part, the mucosa in relation to the proximal three strictures was intact, although there were multiple 1 to 2 mm erythematous patches present. These involved the mucosa covering the diaphragms, as well as the intervening flat mucosa. Gross ulceration was present on either side of the distal diaphragm. These ulcers measured 7x2 cm (proximal ulcer) and 2x0.3 cm (distal ulcer). The bowel wall was not thickened, although the serosal surface showed foci of adhesions and fat creeping round the surface. The terminal ileum was normal.
Histological examination of the diaphragm lesions (Figure 2 ) revealed that the essential abnormality was an expanded core of fibrotic submucosa. At the inner margin of the diaphragms there was a superficial ulcer ( Figure 3 ). These showed a fibrin membrane on the surface, but this did not have the characteristic layering pattern seen in pseudomembranous colitis.
Both sides of the diaphragm were covered by a mucosa that showed patchy inflammation with occasional crypt abscess formation. The large ulcers occurring in flat mucosa were superficial and extended only into the submucosa. Beneath the ulcer bed, there was some patchy transmural inflammation, but no granulomas were identified. The erythematous patches consisted of hemorrhage into mucosal lymphoid follicles. No well defined aphthoid ulcers were seen.
DISCUSSION
NSAIDs are well known to cause a variety of upper gastrointestinal lesions, including acute erosive gastritis (19) and gastric and duodenal ulcers (20) . Typically, these ulcers are not primarily related to Helicobacter pylori in-fection (21) , and organisms are not present in the adjacent mucosa unless there is a coincidental infection.
NSAIDs have also been shown to cause physiological changes in the small intestine, such as an increase in mucosal permeability as assessed by the 51 Cr EDTA absorption test (22) . The cause of this increased permeability is thought to be damage to intercellular junctions, proportional to the drug's ability to inhibit cyclo-oxygenase (23, 24) . This damage to small intestinal mucosa may lead to a loss of blood and protein. The increase in permeability may also lead to increased mucosal exposure to intraluminal toxins and microorganisms.
Morphological abnormalities of the small bowel that have also been linked to NSAIDs include nonspecific ulceration and stricture formation. The strictures generally only involve a very short segment of bowel and may not be accompanied by localized ulceration. Diaphragm disease of the small bowel was first recognized in 1988 (25) , and since then a number of publications have linked it to NSAIDs therapy. The diaphragms morphologically resemble ultrashort segment strictures and are identical to large bowel diaphragms (18) .
The cause of the diaphragm formation in the ascending colon and cecum is unclear. It seems likely that diaphragm disease is only part of the spectrum of NSAID-related conditions of the large bowel. Other manifestations include nonspecific intestinal inflammation (6) (7) (8) 26) , intestinal ulceration, particularly of the cecum (1) (2) (3) (4) 27) , and stricture formation (5, 25) . The pathogenesis of diaphragm production remains obscure, but presumably it represents a minimal stricture in which the fibrosis is localized and confined to the submucosa. Lang et al (18) have postulated that the diaphragms arise as an alteration of the plicae circulares and are a precursor of more extensive flat ulceration. It seems more likely, however, that these lesions are not directly related and that diaphragms develop in ulcerated areas where the normal healing response is inhibited by the action of the anti-inflammatory drug.
In Canada, diclofenac may be prescribed as either enteric-coated tablets (25 or 50 mg) or as slow-release tablets. The slow-release preparations contain 75 or 100 mg of the drug and are intended for once a day administration. While no specific information is available about the enterotoxic effects of each form, it may be speculated that the higher strength slow-release form may be more likely to produce strictures in the small bowel or cecum.
Our patient presented with history of chronic diarrhea and rather vague abdominal pain. She also had hypochromic microcytic anemia. These findings are typical of NSAID-induced strictures. Radiological investigation of the colon did not readily reveal any abnormality, and it was therefore necessary to proceed to colonoscopic examination. The possibility of druginduced enteropathy should be considered in a patient who is on long term NSAID therapy and presents with a history of diarrhea, abdominal pain and blood loss. Diarrhea alone, however, can occur without enteropathy. Although diclofenac is the NSAID most commonly implicated in the formation of diaphragms, other drugs, especially ASA, sulindac and indomethacin, have also been responsible. We consider that the most effective investigation of such patients is with colonoscopy and ileoscopy. The treatment should consist of discontinuation of NSAID therapy. Surgical therapy should be reserved for patients who do not respond to NSAID withdrawal or who develop significant intestinal complications.
